Serotonin type 3 receptor subunit gene polymorphisms associated with psychosomatic symptoms in irritable bowel syndrome: A multicenter retrospective study

doi:10.3748/wjg.v28.i21.2334

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 28, Issue 21

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (13322)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-4) series.

Item

Count

PDF

412

WORD

HTML

8838

Figures (1-2)

649

Tables (1-4)

436

Sum=10418

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

273

Download

592

Sum=865

Publishing Process of This Article

Item

Count

Browse

560

Download

1479

Sum=2039

Jun 7, 2022 (publication date) through Feb 18, 2025

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Jun 7, 2022; 28(21): 2334-2349
Published online Jun 7, 2022. doi: 10.3748/wjg.v28.i21.2334

Table 2 Sociodemographic and symptomatic characteristics of the study participants

	Total	Centers
	Total	Germany	Sweden	United States	United Kingdom	Ireland
n	100.0 (623)	45.1 (281)	18.3 (114)	19.6 (122)	12.4 (77)	4.7 (29)
Age	41.7 ± 16.1 (18, 91)	40.7 ± 16.4 (18, 88)	33.7 ± 11.8 (18, 60)	54.9 ± 14.6 (25, 91)	40.8 ± 11.6 (18, 70)	30.3 ± 8.6 (19, 51)
Sex
Female	69.5 (433)	63.3 (178)	69.3 (79)	77.9 (95)	72.7 (56)	86.2 (25)
IBS subtypes
IBS-C	14.1 (87)	8.9 (25)	12.3 (14)	36.7 (44)	0	13.8 (4)
IBS-D	41.7 (258)	43.4 (122)	19.6 (22)	28.3 (34)	100.0 (77)	10.3 (3)
IBS-M	42.5 (263)	45.6 (128)	67.0 (75)	31.7 (38)	0	75.9 (22)
IBS-U¹	1.8 (11)	2.1 (6)	0.9 (1)	3.3 (4)	0	0
Depressive symptoms	-	9.4 ± 5.9²	5.2 ± 3.5⁴	13.2 ± 9.6⁵	5.9 ± 4.0⁴	4.3 ± 3.2⁴
Anxiety symptoms	-	7.7 ± 4.8³	8.3 ± 4.5⁴	14.6 ± 9.7⁶	9.6 ± 4.6⁴	7.8 ± 4.5⁴
Symptom severity	-	280.3 ± 90.7⁷	297.3 ± 100.5⁷	43.2 ± 16.2⁸	-	-
Somatization symptoms⁹	14.8±6.3	16.2 ± 7.3	13.3 ± 4.7	13.8 ± 5.0	-	-

Sample size, sex, IBS subtypes, and severity of depressive and anxiety symptoms are presented as % (n). Age is presented as mean ± SD (range). Scores of depressive and anxiety symptoms are presented as mean ± SD.

¹Was not included in the later analysis because of the small sample size.

²Evaluated by the nine-item depression module from the Patient Health Questionnaire.

³Evaluated by the brief measurement for generalized anxiety disorder.

⁴Evaluated by Hospital Anxiety and Depression Scale.

⁵Evaluated by Beck Depression Inventory.

⁶Evaluated by Beck Anxiety Inventory.

⁷Evaluated by irritable bowel syndrome (IBS) symptom severity scale.

⁸Evaluated by the gastrointestinal symptom rating scale for IBS.

⁹Evaluated by the somatization module for the Patient Health Questionnaire.

IBS: Irritable bowel syndrome; IBS-C: Constipation-predominant IBS; IBS-D: Diarrhea-predominant IBS; IBS-M: IBS with mixed bowel habits; IBS-U: Unclassified IBS.

Citation: Berens S, Dong Y, Fritz N, Walstab J, D'Amato M, Zheng T, Wahl V, Boekstegers F, Bermejo JL, Martinez C, Schmitteckert S, Clevers E, Engel F, Gauss A, Herzog W, Spiller R, Goebel-Stengel M, Mönnikes H, Andresen V, Thomas F, Keller J, Pehl C, Stein-Thöringer C, Clarke G, Dinan TG, Quigley EM, Sayuk G, Simrén M, Tesarz J, Rappold G, van Oudenhove L, Schaefert R, Niesler B. Serotonin type 3 receptor subunit gene polymorphisms associated with psychosomatic symptoms in irritable bowel syndrome: A multicenter retrospective study. World J Gastroenterol 2022; 28(21): 2334-2349
URL: https://www.wjgnet.com/1007-9327/full/v28/i21/2334.htm
DOI: https://dx.doi.org/10.3748/wjg.v28.i21.2334